Summary: Featuring articles on weekly insulin icodec or daily glargine in type 2 diabetes, an orexin receptor 2 agonist in narcolepsy, neoadjuvant therapy for rectal cancer, and cilta-cel in lenalidomide-refractory multiple myeloma; a review article on artificial intelligence in U.S. health care delivery; a case report of a young man with progressive dyspnea; and Perspective articles on a critical opportunity to improve public health data, on the future of prior-authorization reform, and on curiosity in clinical care. Supplement to the New England Journal of Medicine, Vol. 389, No. 4.
